Article info
Multiple sclerosis
Review
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis
- Correspondence to Dr Alberto Vaona, Primary Care, Azienda ULSS 20 Verona, Ospedale di Marzana, Piazzale Ruggero Lambranzi 1, Verona 37142, Italy; aisamaisa{at}gmail.com
Citation
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis
Publication history
- Received August 15, 2014
- Revised November 4, 2014
- Accepted November 25, 2014
- First published December 30, 2014.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions